Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1995 Dec;32(12):976–978. doi: 10.1136/jmg.32.12.976

Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland.

P Guldberg 1, K F Henriksen 1, I Sipilä 1, F Güttler 1, A de la Chapelle 1
PMCID: PMC1051781  PMID: 8825928

Abstract

The incidence of phenylketonuria (PKU) in Finland is extremely low, probably below 1 in 100,000. We describe the mutations and haplotypes in all four presently known patients. Mutation R408W was found on four mutant chromosomes (all haplotype 2), and IVS7nt1, R261Q, and IVS2nt1 were each found on a single chromosome. No mutation was found on the remaining chromosome. These findings support a pronounced negative founder effect as the cause of the low incidence of PKU in Finland, and are consistent with existing data regarding the European and Baltic origin of Finnish genes.

Full text

PDF
976

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams E. S., Stanton V. P., Jr Use of denaturing gradient gel electrophoresis to study conformational transitions in nucleic acids. Methods Enzymol. 1992;212:71–104. doi: 10.1016/0076-6879(92)12006-c. [DOI] [PubMed] [Google Scholar]
  2. Byck S., Morgan K., Tyfield L., Dworniczak B., Scriver C. R. Evidence for origin, by recurrent mutation, of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet. 1994 Sep;3(9):1675–1677. doi: 10.1093/hmg/3.9.1675. [DOI] [PubMed] [Google Scholar]
  3. Chakraborty R., Lidsky A. S., Daiger S. P., Güttler F., Sullivan S., Dilella A. G., Woo S. L. Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet. 1987 May;76(1):40–46. doi: 10.1007/BF00283048. [DOI] [PubMed] [Google Scholar]
  4. Corner E. M., Grant L. Healed Double Empyema. Proc R Soc Med. 1912;5(CLIN):90–91. [PMC free article] [PubMed] [Google Scholar]
  5. DiLella A. G., Marvit J., Brayton K., Woo S. L. An amino-acid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. 1987 May 28-Jun 3Nature. 327(6120):333–336. doi: 10.1038/327333a0. [DOI] [PubMed] [Google Scholar]
  6. Eisensmith R. C., Goltsov A. A., O'Neill C., Tyfield L. A., Schwartz E. I., Kuzmin A. I., Baranovskaya S. S., Tsukerman G. L., Treacy E., Scriver C. R. Recurrence of the R408W mutation in the phenylalanine hydroxylase locus in Europeans. Am J Hum Genet. 1995 Jan;56(1):278–286. [PMC free article] [PubMed] [Google Scholar]
  7. Eisensmith R. C., Okano Y., Dasovich M., Wang T., Güttler F., Lou H., Guldberg P., Lichter-Konecki U., Konecki D. S., Svensson E. Multiple origins for phenylketonuria in Europe. Am J Hum Genet. 1992 Dec;51(6):1355–1365. [PMC free article] [PubMed] [Google Scholar]
  8. Guldberg P., Henriksen K. F., Güttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics. 1993 Jul;17(1):141–146. doi: 10.1006/geno.1993.1295. [DOI] [PubMed] [Google Scholar]
  9. Guldberg P., Romano V., Ceratto N., Bosco P., Ciuna M., Indelicato A., Mollica F., Meli C., Giovannini M., Riva E. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet. 1993 Oct;2(10):1703–1707. doi: 10.1093/hmg/2.10.1703. [DOI] [PubMed] [Google Scholar]
  10. Hästbacka J., de la Chapelle A., Kaitila I., Sistonen P., Weaver A., Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet. 1992 Nov;2(3):204–211. doi: 10.1038/ng1192-204. [DOI] [PubMed] [Google Scholar]
  11. Hästbacka J., de la Chapelle A., Mahtani M. M., Clines G., Reeve-Daly M. P., Daly M., Hamilton B. A., Kusumi K., Trivedi B., Weaver A. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell. 1994 Sep 23;78(6):1073–1087. doi: 10.1016/0092-8674(94)90281-x. [DOI] [PubMed] [Google Scholar]
  12. Kleiman S., Bernstein J., Schwartz G., Eisensmith R. C., Woo S. L., Shiloh Y. A defective splice site at the phenylalanine hydroxylase gene in phenylketonuria and benign hyperphenylalaninemia among Palestinian Arabs. Hum Mutat. 1992;1(4):340–343. doi: 10.1002/humu.1380010413. [DOI] [PubMed] [Google Scholar]
  13. Lidsky A. S., Ledley F. D., DiLella A. G., Kwok S. C., Daiger S. P., Robson K. J., Woo S. L. Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet. 1985 Jul;37(4):619–634. [PMC free article] [PubMed] [Google Scholar]
  14. Nevanlinna H. R. Genetic aspects of rare neurological diseases. Acta Neurol Scand Suppl. 1978;67:36–55. [PubMed] [Google Scholar]
  15. Nevanlinna H. R. The Finnish population structure. A genetic and genealogical study. Hereditas. 1972;71(2):195–236. doi: 10.1111/j.1601-5223.1972.tb01021.x. [DOI] [PubMed] [Google Scholar]
  16. Norio R., Nevanlinna H. R., Perheentupa J. Hereditary diseases in Finland; rare flora in rare soul. Ann Clin Res. 1973 Jun;5(3):109–141. [PubMed] [Google Scholar]
  17. Palo J. Prevalence of phenylketonuria and some other metabolic disorders among mentally retarded patients in Finland. Acta Neurol Scand. 1967;43(5):573–579. doi: 10.1111/j.1600-0404.1967.tb05552.x. [DOI] [PubMed] [Google Scholar]
  18. Workman P. L., Mielke J. H., Nevanlinna H. R. The genetic structure of finland. Am J Phys Anthropol. 1976 Mar;44(2):341–367. doi: 10.1002/ajpa.1330440216. [DOI] [PubMed] [Google Scholar]
  19. de la Chapelle A. Disease gene mapping in isolated human populations: the example of Finland. J Med Genet. 1993 Oct;30(10):857–865. doi: 10.1136/jmg.30.10.857. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES